Non-NICE reports

Non-NICE TARs or short reports vary in complexity. These could be solely a systematic review of the evidence or a full evaluation including a mathematical model and assessment of cost-effectiveness.

Off

2024 | 2022 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2006

2024

Effectiveness of interventions for people with problem alcohol and drug use that have co-occurring mental disorders or co-occurring neurocognitive disorders [NIHR166951].

2022

Modelling approaches for site-agnostic cancer drugs to inform NICE appraisal [NIHR127852].

2020

Review on patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) [17/48/01].

2018

Ultrasonography for monitoring of synovitis in rheumatoid arthritis (14/16/01).

The prognostic value of tests and assessment tools in rheumatoid arthritis (14/151/08).

2017

Cost-effectiveness of treat-to-target strategies in rheumatoid arthritis (14/17/01).

2016

Exploratory analyses in the NICE STA process (14/151/04).

2015

Cannabis cessation therapy for regular cannabis users (13/70/01).

Interventions to treat premature ejaculation: a systematic review short report (13/12/01).

The clinical effectiveness and cost-effectiveness of exercise referral schemes (13/45/01).

2014

Routine echocardiography in the management of stroke and TIA (09/68/01).

The effectiveness of sexual health interventions for people with severe mental illness: a systematic review (12/74/01).

Cytisine for smoking cessation (12/46/01).

2013

Eculizumab for atypical haemolytic uraemic syndrome (aHUS) (AGNSS project) (11/91/01).

Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation (10/29/01).

Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation (08/45/01).

Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation (09/107/01).

2012

The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review (09/142/01).

2011

The clinical effectiveness and safety of prophylactic retinal interventions to reduce the risk of retinal detachment and subsequent vision loss in adults and children with Stickler syndrome (09/23/01).

Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis (08/228/01).

Hemiarthroplasty and total hip arthroplasty for treating a primary intracapsular fracture of the hip: a systematic review and cost-effectiveness analysis (09/108/02).

2010

Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review (07/54/01).

2009

Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review (06/27/01).

Vitamin K to prevent fractures in older women: systematic review and economic evaluation (07/16/01).

Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation (07/03/01).

A study to establish the feasibility of a trial that would investigate the clinical and cost-effectiveness of stopping bisphosphonate treatment after 5 years in post-menopausal women with osteoporosis who have already had a fracture (06/31/01).

2006

Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation (04/52/01)